logo-loader
Energy
BP PLC

Plugged in: BP to buy the UK's largest electric vehicle charging company, Chargemaster

In a statement yesterday, BP said: "The development of convenient and innovative EV charging technologies and networks is a key part of BP's strategy to advance the energy transition"

Electric vehicles charging
BP said its customers in the UK should be able to access BP Chargemaster chargers on forecourts over the next 12 months

BP PLC (LON:BP.) has agreed to buy the UK's largest electric vehicle (EV) charging company, Chargemaster, as the oil giant comes to terms with the move away from the use of fossil fuels.

The FTSE 100-listed firm did not disclose its purchase price for Chargemaster – to be rebranded as BP Chargemaster after the deal completes – which operates a network of EV charging points, with over 6,500 across the country. It also designs, builds, sells and maintains EV charging units.

READ: BP posts ‘strongest quarter’ since 2014, thanks to rising output, higher crude prices

In a statement yesterday, BP said: "The development of convenient and innovative EV charging technologies and networks is a key part of BP's strategy to advance the energy transition.

“BP is committed to developing new offers to meet changing customer demand and growing new businesses and supporting opportunities for customers to reduce their emissions."

The oil firm added that BP customers in the UK should be able to access BP Chargemaster chargers on forecourts over the next 12 months.

BP estimates that by 2040 there will be 12mln electric vehicles on UK roads, up from around 135,000 in 2017.

Tufan Erginbilgic, chief executive of BP Downstream commented: "Combining BP's and Chargemaster's complementary expertise, experience and assets is an important step towards offering fast and ultra-fast charging at BP sites across the UK and to BP becoming the leading provider of energy to low carbon vehicles, on the road or at home.”

Quick facts: BP PLC

Price: £4.93

Market: LSE
Market Cap: £100.57 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Kazia Therapeutics reaches milestone for Phase 1 Cantrixil trial in ovarian...

Kazia Therapeutics Limited (ASX:KZA) chief executive officer Dr James Garner updates Proactive Investors on a milestone for the company, with the completion of recruitment for Cantrixil its Phase 1 clinical trial in ovarian cancer. The CEO said the first part of the study has shown some very...

3 hours, 7 minutes ago

RNS

Transaction in Own Shares

21 hours, 1 minute ago

Holding(s) in Company

6 days, 12 hours ago

Transaction in Own Shares

1 week, 1 day ago

Transaction in Own Shares

1 week, 2 days ago

Holding(s) in Company

2 weeks ago

2 min read